These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26983886)

  • 1. Enzymatic Targets in Trypanosoma brucei.
    Scotti L; Mendonça FJ; da Silva MS; Scotti MT
    Curr Protein Pept Sci; 2016; 17(3):243-59. PubMed ID: 26983886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of trypanothione reductase as a drug target in Trypanosoma brucei.
    Spinks D; Shanks EJ; Cleghorn LA; McElroy S; Jones D; James D; Fairlamb AH; Frearson JA; Wyatt PG; Gilbert IH
    ChemMedChem; 2009 Dec; 4(12):2060-9. PubMed ID: 19924760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.
    Turcano L; Battista T; De Haro ET; Missineo A; Alli C; Paonessa G; Colotti G; Harper S; Fiorillo A; Ilari A; Bresciani A
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008339. PubMed ID: 32437349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
    Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
    Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition.
    Ferreira LG; Andricopulo AD
    Future Med Chem; 2013 Oct; 5(15):1753-62. PubMed ID: 24144411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
    Zimmermann S; Oufir M; Leroux A; Krauth-Siegel RL; Becker K; Kaiser M; Brun R; Hamburger M; Adams M
    Bioorg Med Chem; 2013 Nov; 21(22):7202-9. PubMed ID: 24080104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
    Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione Reductase.
    De Gasparo R; Halgas O; Harangozo D; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    Chemistry; 2019 Sep; 25(49):11416-11421. PubMed ID: 31407832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi.
    Jones DC; Ariza A; Chow WH; Oza SL; Fairlamb AH
    Mol Biochem Parasitol; 2010 Jan; 169(1):12-9. PubMed ID: 19747949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei.
    Lu J; Vodnala SK; Gustavsson AL; Gustafsson TN; Sjöberg B; Johansson HA; Kumar S; Tjernberg A; Engman L; Rottenberg ME; Holmgren A
    J Biol Chem; 2013 Sep; 288(38):27456-27468. PubMed ID: 23900839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness.
    Durrant JD; Urbaniak MD; Ferguson MA; McCammon JA
    J Med Chem; 2010 Jul; 53(13):5025-32. PubMed ID: 20527952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Virtual Screening and Biochemical Evaluation for the Identification of Novel Trypanosoma brucei Aldolase Inhibitors.
    Ferreira LLG; Ferreira RS; Palomino DL; Andricopulo AD
    Curr Top Med Chem; 2018; 18(5):397-405. PubMed ID: 29701141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the
    Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ
    Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
    Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
    Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei.
    Roper JR; Guther ML; Milne KG; Ferguson MA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5884-9. PubMed ID: 11983889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity.
    Martyn DC; Jones DC; Fairlamb AH; Clardy J
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1280-3. PubMed ID: 17197182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
    Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
    Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani.
    Chibale K; Visser M; Yardley V; Croft SL; Fairlamb AH
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1147-50. PubMed ID: 10866368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.